Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cabaletta Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 55 | 54 | −1 |
| Shares | 16.8M | 11.9M | −4.87M (−29.0%) |
| Value | $17.8M | $7.76M | −$10.1M (−56.5%) |
New holders (9)
Institutions that held Cabaletta Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eversept Partners, LP | 560,466 | $364.4K | 0.04% |
| Privium Fund Management (UK) Ltd | 331,218 | $215.0K | 0.28% |
| UBS Group AG | 50,000 | $33.0K | 0.00% |
| Two Sigma Securities, LLC | 13,594 | $9.00K | 0.00% |
| Virtu Financial LLC | 14,070 | $9.00K | 0.00% |
| Group One Trading, L.P. | 6,373 | $4.00K | 0.00% |
| Royal Bank of Canada | 384 | $0 | 0.00% |
| Cutler Group LP | 600 | $0 | 0.00% |
| China Universal Asset Management Co., Ltd. | 272 | $0 | 0.00% |
Sold out (10)
Institutions that held Cabaletta Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| 5AM Venture Management, LLC | 2,064,263 | $2.19M |
| Samlyn Capital, LLC | 1,919,907 | $2.04M |
| Citadel Advisors LLC | 1,254,479 | $1.33M |
| DLD Asset Management, LP | 246,500 | $261.0K |
| Piper Sandler & Co. | 145,000 | $154.0K |
| Dimensional Fund Advisors LP | 19,863 | $21.0K |
| HSBC Holdings PLC | 13,227 | $14.0K |
| IHT Wealth Management, LLC | 12,240 | $13.0K |
| Howe & Rusling Inc | 100 | $0 |
| Captrust Financial Advisors | 200 | $0 |